Wijermans, P W <br/><br/>
Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome.  [electronic resource] 

 -  Leukemia  Jan 1997 
 - 1-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2400526  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Aged, 80 and over<br/>Anemia, Refractory--drug therapy<br/>Anemia, Refractory, with Excess of Blasts--drug therapy<br/>Antineoplastic Agents--adverse effects<br/>Azacitidine--adverse effects<br/>Decitabine<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Leukemia, Myelomonocytic, Chronic--drug therapy<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Pancytopenia--chemically induced